Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, and structure-activity relationship of programmed cell death-1/programmed cell death-ligand 1 interaction inhibitors bearing a benzo[d]isothiazole scaffold
Hao Chen, Ke Wang, Yang Yang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 217, pp. 113377-113377
Closed Access | Times Cited: 14

Showing 14 citing articles:

PD-1/PD-L1 and DNA Damage Response in Cancer
Mateusz Kciuk, Damian Kołat, Żaneta Kałuzińska‐Kołat, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 530-530
Open Access | Times Cited: 22
Small-molecule modulators of tumor immune microenvironment
Jing Zhang, Jia Yu, Meijing Liu, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107251-107251
Closed Access | Times Cited: 5
A computational chemistry-based approach to optimizing PD-1/PD-L1 inhibitors
Meijuan Zhai, Shiliang Ji, Haoran Hu, et al.
Frontiers in Chemistry (2025) Vol. 12
Open Access
Discovery and Crystallography Study of Novel Biphenyl Ether and Oxadiazole Thioether (Non-Arylmethylamine)-Based Small-Molecule PD-1/PD-L1 Inhibitors as Immunotherapeutic Agents
Jin Liu, Yao Cheng, L. Yuan, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 18, pp. 13172-13188
Closed Access | Times Cited: 13
PD-L1 Inhibitors: Different Classes, Activities, and Mechanisms of Action
Ewa Surmiak, Katarzyna Magiera‐Mularz, Bogdan Musielak, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11797-11797
Open Access | Times Cited: 27
N-methylmorpholine incorporation into the structure of biphenyl leads to the bioactive inhibitor of PD-1/PD-L1 interaction
Julia Ząber, Łukasz Skalniak, Ganna P. Gudz, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 110, pp. 129882-129882
Open Access | Times Cited: 2
Discovery of phenyl-linked symmetric small molecules as inhibitors of the programmed cell death-1/programmed cell death-ligand 1 interaction
Yizhe Wu, Yu Zhang, Yu Guo, et al.
European Journal of Medicinal Chemistry (2021) Vol. 223, pp. 113637-113637
Closed Access | Times Cited: 19
Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction
Yu Wang, Kun Huang, Yali Gao, et al.
European Journal of Medicinal Chemistry (2021) Vol. 229, pp. 113998-113998
Closed Access | Times Cited: 15
Advances of Biphenyl Small-Molecule Inhibitors Targeting PD-1/PD-L1 Interaction in Cancer Immunotherapy
Roufen Chen, Dandan Yuan, Junjie Ma
Future Medicinal Chemistry (2021) Vol. 14, Iss. 2, pp. 97-113
Closed Access | Times Cited: 14
Review: PD‐L1 as an emerging target in the treatment and prevention of keratinocytic skin cancer
Prajakta Vaishampayan, Clara Curiel‐Lewandrowski, Sally E. Dickinson
Molecular Carcinogenesis (2022) Vol. 62, Iss. 1, pp. 52-61
Open Access | Times Cited: 10
Novel hybrid benzoisothiazole-1,2,3-triazole-4-carboxamides with sub-micromolar toxicity towards human breast carcinoma cells and high affinity to DNA
Nazariy T. Pokhodylo, M. Tupychak, Nataliya Finiuk, et al.
Journal of Molecular Structure (2024) Vol. 1314, pp. 138743-138743
Closed Access | Times Cited: 1
Progress on biphenyl derivatives as PD-1/PD-L1 inhibitors
Shu‐Rong Wang, Yuli Wang, Hong Yan
Medicinal Chemistry Research (2023) Vol. 32, Iss. 10, pp. 2089-2115
Closed Access | Times Cited: 4
Current Medicinal Insights on Synthetic Small Molecules and Natural Origin Products as PD-1/PD-L1 Inhibitors
Shivanshu Pandey, Balak Das Kurmi, Preeti Patel
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 18, pp. 1765-1781
Closed Access | Times Cited: 2
Progress in programmed cell death-1/programmed cell death-ligand 1 pathway inhibitors and binding mode analysis
Xiaoyun Li, Qin Zeng, Fengjiao Xu, et al.
Molecular Diversity (2022) Vol. 27, Iss. 4, pp. 1935-1955
Closed Access | Times Cited: 2
Page 1

Scroll to top